Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Novo Nordisk A/S ADR
(NY:
NVO
)
125.42
+1.72 (+1.39%)
Streaming Delayed Price
Updated: 2:27 PM EDT, Sep 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
3,579,663
Open
124.32
Bid (Size)
125.41 (1)
Ask (Size)
125.44 (1)
Prev. Close
123.70
Today's Range
123.77 - 126.66
52wk Range
86.96 - 148.15
Shares Outstanding
N/A
Dividend Yield
1.41%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Novo Nordisk To Consider Ways For Patients To Affordably Access Weight Loss Drugs Ozempic, Wegovy, Says CEO
Today 12:52 EDT
Novo Nordisk CEO commits to exploring ways to make weight-loss drugs more affordable for U.S. patients after hearing from Congress.
Via
Benzinga
Novo Nordisk's Options: A Look at What the Big Money is Thinking
Today 11:30 EDT
Via
Benzinga
Performance
YTD
+22.83%
+22.83%
1 Month
-7.30%
-7.30%
3 Month
-11.85%
-11.85%
6 Month
-2.81%
-2.81%
1 Year
+37.63%
+37.63%
More News
Read More
Aligos Therapeutics Strengthens Senior Leadership Team with the Appointment of Hardean Achneck, MD as Chief Medical Officer
Today 8:00 EDT
From
Aligos Therapeutics
Via
GlobeNewswire
'Miracle' Weight Loss Drug Ozempic To Enter US Price Negotiations Within A Year, Novo Nordisk CEO Says Ahead Of Senate Hearing
Today 5:48 EDT
Via
Benzinga
Novo Nordisk's Options: A Look at What the Big Money is Thinking
September 23, 2024
Via
Benzinga
Spotlight on Novo Nordisk: Analyzing the Surge in Options Activity
September 19, 2024
Via
Benzinga
2 Weight-Loss Stocks That Could Rocket Higher This Year
Today 4:57 EDT
Via
The Motley Fool
Nasdaq-Traded Cannabinoid Biotech Corbus Pharma Stock Plunges 60%, But Analysts Say 'Buy The Dip' Now
September 23, 2024
Via
Benzinga
Novo Nordisk CEO To Face Senate Scrutiny Over High Ozempic And Wegovy Prices, Hearing Scheduled On Tuesday
September 23, 2024
Via
Benzinga
Bernie Sanders Questions Why Your Monthly Ozempic Prescription Costs More Than A Luxury Handbag When It Can Be Sold For Less Than $100
September 22, 2024
Via
Benzinga
Novo Nordisk, Chewy And FedEx Are Among Top 10 Large Cap Losers Last Week (Sept 15-Sept 21): Are The Others In Your Portfolio?
September 22, 2024
Via
Benzinga
3 Stocks That Could Rise on European Bank Interest Rate Cuts
September 22, 2024
Via
MarketBeat
Topics
Economy
Exposures
Interest Rates
Netflix, Eli Lilly Lead 5 Fast Growers Near Buy Points
September 21, 2024
Via
Investor's Business Daily
Why Novo Nordisk Stock Fell While Eli Lilly and Viking Therapeutics Bumped Higher Today
September 20, 2024
Via
The Motley Fool
US Federal Trade Commission Sues CVS Health, Cigna, UnitedHealth's Pharmacy Benefit Managers For Inflating Insulin Prices
September 20, 2024
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
Novo Nordisk's Monlunabant Data Drags Stocks Of Smaller Players
September 20, 2024
Via
Benzinga
Corbus Pharma (CRBP) Stock Drops 60% After Novo Nordisk's Cannabinoid-Based Weight Loss Drug Trial Disappoints
September 20, 2024
Via
Benzinga
Novo Nordisk Stock Declines After Headline Results From Mid-Stage Study Of Monlunabant In Obese Patients
September 20, 2024
Via
Benzinga
Novo Dives — And Corbus Crashes — After New Weight-Loss Drug Causes Neuropsychiatric Effects
September 20, 2024
Via
Investor's Business Daily
European Drug Agency Supports Novo Nordisk's Blockbuster Weight-Loss Drug Wegovy For Obesity-Related Heart Failure
September 20, 2024
Via
Benzinga
Hims & Hers To Offer Access To Compounded Diabetes And Weight Loss Drugs For Just $99/Month To Certain Professional Personnel
September 19, 2024
Via
Benzinga
Viking Therapeutics Is Having a Year to Remember: Time to Buy?
September 19, 2024
Via
MarketBeat
Novo Nordisk Just Took a $530 Million Step Onto Moderna's Turf. Here's What It Means for Both Stocks
September 19, 2024
Via
The Motley Fool
Novo Nordisk Inks $600M Genetic Medicines Pact With Canadian Firm To Target Cardiometabolic Indications
September 18, 2024
Via
Benzinga
1 Telemedicine Stock I Wouldn't Touch With a 10-Foot Pole (Hint: It's Not Teladoc)
September 17, 2024
Via
The Motley Fool
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.